A DOJ Press Release reports that "Cell Therapeutics Inc. (CTI) of Seattle, Wash., has agreed to pay the United States $10.5 million to resolve allegations of the company’s illegal marketing of the anti-cancer prescription drug Trisenox."  This case was resolved by the Department of Justice within the civil division.

(esp)